Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients.

Sah, A; Barrans, S L; Parapia, L A; Jack, A S; Owen, R G

Sah, A; Barrans, S L; Parapia, L A; Jack, A S; Owen, R G.

Affiliation

Sah A; HMDS, Leeds General Infirmary, Leeds, United Kingdom. anitasah@doctors.org.uk

Am J Hematol ; 75(4): 195-9, 2004 Apr.

Article in En | MEDLINE | ID: mdl-15054808

Subject(s)

Lymphoma, B-Cell/pathology; Lymphoma, B-Cell/therapy; Skin Neoplasms/pathology; Skin Neoplasms/therapy; Adolescent; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Lymphoma, B-Cell Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Am J Hematol Year: 2004 Document type: Article

Search on Google

XML

PubMed Links